The spindle assembly checkpoint (SAC) guards against chromosomal mis-segregation and the emergence of aneuploidy. SAC in higher eukaryotes includes at least 10 proteins including MAD1-3, BUB1-3, and Msp1. A long-standing observation has been that rodent cells are more tolerant of microtubule toxins than primate cells indicating that SAC function is more relaxed in the former than the latter. Here, we report on an unexpected functional difference between the rodent and human MAD1 component of the respective SAC. Ectopic expression of human MAD1 in mouse and hamster cells corrected a relaxed SAC to a more stringent form. Our findings posit MAD1 as a species-specific determinant which influences the stringency of cellular response to microtubule depolymerization and spindle damage.
Introduction
Rodents and humans share many regulatory pathways. Interestingly, the two species require markedly different length of time to accumulate genetic changes needed for tumor development (Hahn and Weinberg, 2002) . Thus, rodent cells are more easily transformed in vitro than human cells, and it has been estimated that the spontaneous transformation frequency for human fibroblasts in culture is approximately 10 À9 -10
À10
, while the corresponding rodent frequency ranges from 10 À5 to 10 À6 (Holliday, 1996) . Consistent with this rather dramatic difference, recent molecular studies have revealed divergences between growth controls in rodent and human cells. For example, the cell cycle mechanism which permits premature induction of chromosome condensation with caffeine or okadaic acid is seen in rodent, but not in human, cells (Downes et al., 1990; Steinmann et al., 1991) , and telomerase activity is constitutive in primary murine, but not in primary human, cells (Wright and Shay, 2000) . Moreover, a simpler combination of oncogenes is needed to transform rodent, than human, cells (Rangarajan et al., 2004) , and morphological progression of benign adenomas to carcinomas occurs more frequently and facilely in mouse than in human (Haines et al., 2001) .
More than 10 years ago, Schimke and co-workers reported another salient difference between rodent and human cells. Using microtubule depolymerizing drugs, they noted that in response to mitotic spindle disruption, human cells arrested cell cycle progression in metaphase while rodent cells continued to progress, leading to multiplication of DNA content (Kung et al., 1990; Schimke et al., 1991) . Such an apparently relaxed mitotic checkpoint may contribute to genomic instability which could subsequently lead to neoplastic transformation (Schimke et al., 1991; Hartwell, 1992; Murray, 1992; Lengauer et al., 1997; Duesberg and Li, 2003) . A relaxed spindle checkpoint might be one of several factors that contribute to the elevated frequency of transformation in mice (Michel et al., 2001; Dai et al., 2004; Rao et al., 2005) . To date, a molecular explanation for the apparently different stringency between human and rodent spindle assembly checkpoint (SAC) remains unknown.
The eukaryote SAC ensures fidelity of sister chromatid separation during mitosis by monitoring proper microtubule attachment to and alignment of metaphase chromosomes in preparation for anaphase (Shah and Cleveland, 2000; Musacchio and Hardwick, 2002; Bharadwaj and Yu, 2004; Rieder and Maiato, 2004) . Initially, seven proteins were identified as SAC components in yeast (i.e. Bub1-3, Mad1-3, and Mps1) (Hoyt and Geiser, 1996; Rudner and Murray, 1996; Weiss and Winey, 1996) ; additional factors such as CENP-E, ZW10, Rod and Rae1 (Abrieu et al., 2000; Basto et al., 2000; Babu et al., 2003) were later proposed for metazoan SAC. The importance of SAC in normal cellular metabolism is reflected in its frequent dysfunction in human cancers (Draviam et al., 2004; Lengauer and Wang, 2004) , and in its role for dictating cellular responsiveness to chemotherapeutic agents Vogel et al., 2005) . Accordingly, a better understanding of the molecular bases, which influence SAC stringency in higher eukaryotes, could uncover novel targets for treating neoplasia.
We and others have been interested in the role of the human MAD1 protein in SAC function Lee and Spencer, 2004; Li et al., 2004; Shah et al., 2004) . Here, we report on an unexpected species-specific functional difference between human and rodent MAD1 proteins. Our findings suggest that the N-terminus of MAD1 contributes to the stringency of eukaryotic SAC in its response to microtubule depolymerizing agent.
Results
Rodent cells have a relaxed checkpoint response to nocodazole More than 10 years ago, Schimke et al. (1991) (Kung et al., 1990) reported that human and rodent cells behaved differently when exposed to microtubule interfering agents. When treated with such drugs, human cells halted mitosis while rodent cells continued to progress and exited mitosis. As we are interested in how HTLV-1-transformed cells (reviewed in Matsuoka, 2005; Azran et al., 2004) respond to microtubule depolymerizing agents , we revisited Schimke and co-workers' original observations in an attempt to find a molecular explanation.
We treated human (HeLa), mouse (NIH3T3), rat (Rat2), and hamster (CHO) cells with nocodazole, a microtubule depolymerizing drug. Human cells arrested in mitosis with a rapid increase in mitotic index by 12 h (HeLa; Figure 1a , top). By contrast, mouse, rat, and hamster cells showed modest increases (by 12 h) in mitotic indices which quickly reverted to baseline by 24-48 h (NIH3T3, CHO, Rat2; Figure 1a , top). We, next, measured cellular viabilities in response to nocodazole treatment using a modified MTT assay which monitors cellular viability by quantifying the activity of the mitochondrial dehydrogenase enzyme (Figure 1a, bottom) . Here, nocodazole-treated HeLa cells were less viable and had reduced MTT values than similarly treated NIH3T3, CHOK1, or Rat2 cells (Figure 1a, bottom) . Finally, we also viewed HeLa and NIH3T3 cells cultured in the presence of nocodazole by light microscopy. Visually, we observed that HeLa cells arrested division and succumbed to cell death upon prolonged (i.e. 24-48 h) drug exposure ( Figure 1b (Kung et al., 1990) and support the presence of a more relaxed and nocodazoletolerant SAC in rodent cells.
Ectopic expression of human MAD1 adds stringency to the relaxed SAC in rodent cell The above findings raised the possibility that one or more SAC components might be functionally or physically different between rodents and human. To consider this possibility, we cloned and compared the sequences of human (hsMAD1; AF083811), mouse (muMAD1; AF083812), and hamster (AY247792) MAD1 cDNAs. Virtual translation of mouse and hamster (both 717 amino acids) and human (718 amino acids) MAD1 revealed that the rodent and human proteins differ in length by only one amino acid (Figure 2 ), and are well conserved with 81-84% amino-acid identities throughout. There were no overtly large deletions/substitutions between rodent and human MAD1 which might easily explain functional differences. In a similar comparison, we found that mouse (U83902) and human (U65410) MAD2 proteins were both 205 amino acids in length and were even better conserved (94% amino-acid identities) than MAD1 (data not shown).
Since sequence comparisons between rodent and human MAD1 proteins were not overtly informative for differences, we wondered next if variations in function could be revealed through complementation studies. To investigate this possibility, we cotransfected a GFP-expressing plasmid (pEGFP) with either an hsMAD1 plasmid or a muMAD1 plasmid separately into NIH3T3 cells (Figure 3 ). Cells that fluoresced green were scored as those which have received either pEGFP þ hsMAD1 or pEGFP þ muMAD1. Since NIH3T3 cells arrest weakly, if at all, in response to cultivation in nocodazole (Figure 1 ), we checked if transfected hsMAD1 would complement cell endogenous mouse MAD1 to confer a more stringent humanlike nocodazole-induced arrest. In the absence of nocodazole treatment, as expected, we found that both pEGFP þ hsMAD1 (green cells, Figure 3a and b) and pEGFP þ muMAD1 (green cells, Figure 3e and f) cells looked similar and were morphologically flat with each cell containing a single nucleus. On the other hand, when cells were cultured in nocodazole, pEGPF þ Figure 3g and h) became multinucleated, consistent with failed arrest and unchecked aberrant mitotic progression. In three independent experiments, we noted that ectopic expression of hsMAD1 reduced by 5-8-fold the propensity in mouse cells for unarrested nocodazole-induced mitotic aberrancies (see below, Figure 6 ). Hence, our findings support that NIH3T3 cells acquired a more stringent SAC when complemented with hsMAD1.
We next verified the above results using a slightly different protocol. Previously, we found that a GFPhsMAD1 fusion protein retained both checkpoint function and green fluorescent activity . Since there is a significant likelihood that cells transfected with physically unlinked GFP and MAD1 plasmids and fluoresce green (Figure 3 ) may not necessarily have received both plasmids, we repeated the assay using plasmids that express either GFP-hsMAD1 or GFP-muMAD1 fusion proteins. Accordingly, GFPhsMAD1 ( Figure 3 , these findings indicate that overexpression of hsMAD1 was sufficient to complement a relaxed rodent checkpoint to a correspondingly more stringent human form. This sufficiency in complementation suggests that MAD1 may be the singular SAC factor different between human and rodent cells, and that this single factor difference adequately explains observed species-specific stringencies in nocodazole response.
We further extended the above transient transfection results by creating hamster cell lines that stably overexpress human MAD1 protein. Using G418 selection, we established several CHOK1-derived clones that expressed stably, albeit at different levels, human MAD1 ( Figure 5a ). We then compared the behavior of a high hsMAD1-expressing CHOK1 clone (cl 7, Figure 5a , lane 4) to a low hsMAD1-expressing clone (cl 8, Figure 5a , lane 5) in nocodazole cultivation. We observed that in the presence of nocodazole over the course of 48 h, the former arrested cell proliferation while the latter did not (Figure 5b ). Three other CHOK1 cell lines (two high hsMAD1 expressors and one low hsMAD1 expressor) were tested, and they also supported this correlation (data not shown). Overall, these findings are consistent with results in Figure 1 and support the interpretation that ectopic human MAD1 confers to rodent cells a more stringent SAC response not otherwise provided by cell endogenous rodent MAD1.
Human MAD1 competes better than mouse MAD1 for association with kinetochores MAD1 and MAD2 coalesce together at kinetochores to monitor proper microtubule attachment (Bharadwaj and Yu, 2004) . While MAD2 binds CDC20 and inhibits the proteolysis of cyclin B and Pds1 by APC/ C (Wassmann and Benezra, 1998; Fang, 2002; Yu, 2002) , to date, the single inferred function for MAD1 is to bind and recruit MAD2 to kinetochores (Chen et As kinetochore localization of MAD2 is necessary for spindle assembly checkpoint function (Chung and Chen, 2002) , how efficiently MAD1 binds kinetochores may dictate downstream MAD2-dependent checkpoint events.
We wondered if the stringent versus relaxed phenotypes of primate and murine SAC might correlate with the relative affinities of human MAD1 and mouse MAD1 for kinetochores. To address this issue, we devised a qualitative in vivo competition between GFP-tagged human MAD1 (or GFP-tagged murine MAD1) and cell endogenous untagged mouse MAD1 (or untagged human MAD1) for occupancy of kinetochores. We transfected GFP-muMAD1 and GFPhsMAD1 separately into either NIH3T3 (left) or HeLa ( Figure 6 ) cells. We checked that equal expression levels of transfected GFP-muMAD1 and GFP-hsMAD1 were attained by Western blot using anti-GFP (data not shown), and then asked how efficiently the introduced fluorescent muMAD1 or hsMAD1 would occupy kinetochores in competition with cell-endogenous untagged MAD1. Reproducibly, in NIH3T3 cells, GFP-hsMAD1 appeared at expected positions for centromeres demonstrating effective decoration of mouse kinetochores (Figure 6b ). On the other hand, at equal levels of expression in HeLa cells, GFP-muMAD1 failed to appear at human kinetochores (Figure 6h ). In control transfections, both GFP-hsMAD1 and GFPmuMAD1, as expected, located to their respective species-homologous kinetochores (Figure 6d and f) demonstrating that fluorescent GFP-muMAD1 was indeed capable of kinetochore occupancy. We interpret these results to mean that GFP-hsMAD1 competed effectively against untagged muMAD1, but GFPmuMAD1 did not compete effectively against untagged hsMAD1. This supports a higher affinity by hsMAD1 compared to muMAD1 for mammalian kinetochore.
Species-specific property maps to the N-terminus of MAD1
If the above interpretation is correct, then one should be able to map a species-specific determinant to a discrete portion of MAD1. As shown in Figure 2 , the primary amino-acid sequences for mouse and human MAD1 are 81-84% identical throughout. Using a convenient restriction site, we created two in-frame human-mouse (hs/mu) and mouse-human (mu/hs) chimeric MAD1 fusion proteins (Figure 7a ). Hs/muMAD1 contains amino acids 1-349 from human and 350-717 from mouse protein. Mu/hsMAD1 contains amino acids 1-304 from mouse and 305-718 from human protein. We verified that the chimeric (hs/muMAD1, mu/hsMAD1) as well as the wild-type (hsMAD1, muMAD1) proteins all expressed comparably when transfected into either human (Hct116) or mouse (NIH3T3) cells (Figure 7b) .
We next compared hs/muMAD1, mu/hsMAD1, hsMAD1, and muMAD1 for checkpoint activity in mouse cells. We transfected individually hsMAD1, muMAD1, hs/muMAD1, or mu/hsMAD1 into either primary mouse embryo fibroblasts (MEF, Figure 7c ) or NIH3T3 cells (Figure 7d ) and monitored for nocodazoletriggered arrest. When treated with nocodazole for 24 to 36 h, muMAD1-expressing and mu/hsMAD1-expressing MEF and NIH3T3 cells became multinucleated. By contrast, nocodazole-treated hsMAD1-expressing and hs/muMAD1-expressing MEF and NIH3T3 cells were mononucleated. The former is consistent with a relaxed SAC with ensuing aberrant mitotic progression, while the latter is compatible with effective mitotic arrest. Thus, these results correlate the N-terminus of MAD1 with species-specific SAC stringency. Regardless of the C-terminus, MAD1 protein with a human N-terminus presents a more stringent checkpoint function than a counterpart protein with a mouse N-terminus. Based on counting 300 green cells each from three independent experiments, we quantified that expression of hsMAD1 MAD1 and stringent spindle checkpoint K Haller et al N-terminus-containing protein, compared to the corresponding muMAD1 N-terminus-containing protein, in MEF and NIH3T3 cells provided a 5-8fold reduction in aberrant mitosis (Figure 7e and f) .
The above findings do not offer a physical explanation for the functional distinction between human and mouse MAD1. However, it is possible that hsMAD1 and muMAD1 might be regulated differently at the post-translation level. Interestingly, despite human and mouse MAD1 proteins differing in size by a single amino acid (Figure 2) , we noted that mouse MAD1 in NIH3T3 cells (Figure 7b , lane 6) migrated with a distinctly faster mobility than human MAD1 in Hct116 cells (Figure 7b, lane 1) . To verify that this is an observation generally applicable to many primate and rodent cells, we compared side-by-side Western blotting profiles of MAD1 from several additional cells including human (HeLa, A549), rat (Rat2), hamster (CHOK1), and mouse (NIH3T3) (Figure 8a ). Consistent with the results in Figure 7b , human MAD1 from both HeLa and A549 cells electrophoresed B3 kDa larger in denaturing SDS/PAGE than counterpart mouse, hamster, and rat proteins (Figure 8a , compare lanes 1, 2 to 3, 4, 5). To rule out that the observed migrations may be artefacts of transformed cells, we checked two primary cells, freshly prepared mouse embryo fibroblasts (MEF, Figure 8a , lane 7) and primary human foreskin fibroblasts (Foreskin, Figure 8a , lane 9), and compared them to A549 and CV-1 (an African green monkey kidney cell line) cells. Human MAD1 from primary foreskin migrated indistinguishably from MAD1 proteins from the two established primate cells, A549 and CV-1, and again electrophoresed B3 kDa larger than mouse MAD1 from primary MEFs (Figure 8a , lanes 6-9). As control, we also compared the migration of MAD2 proteins from A549, MEF, CV-1, and foreskin ( Figure 8a , lanes 6-9, right). All MAD2 proteins migrated the same in SDS-PAGE (MAD2; Figure 8a , lanes 1-4). Collectively, the results are compatible with the notion that rodent and primate MAD1, but perhaps not MAD2, may be differentially modified post-translationally.
To shed additional light on differences between human and mouse forms, we separately isolated hsMAD1 and muMAD1 proteins to single-band purity for mass spectrometric (MS) comparisons (Figure 8b ). Both proteins were identically processed and treated with trypsin and then subjected to peptide-MS sequencing. Excellent and generally comparable peptide coverage (red sequences) throughout both human and mouse MAD1 proteins was obtained. Interestingly, on repeated attempts, while we consistently recovered the extreme N-terminal peptide fragment from hsMAD1, we failed to obtain the virtually sequence-identical corresponding N-terminal fragment from muMAD1 (see red for hsMAD1 and black italic for muMAD1). We note with interest that the 'medlgenttvlsslrslnnfisqr' N-terminus of muMAD1 differs from the corresponding hsMAD1 at two potential phosphor-acceptor sites (underlined). Indeed, 2-dimensional iso-electric focusing analysis of human and mouse MAD1 proteins showed multiple MAD1 and stringent spindle checkpoint K Haller et al spots for both proteins consistent with several distinct phosphorylation sites in each protein (Figure 8c ). We note that the 2D-profiles between hsMAD1 and muMAD1 are nonidentical; this is compatible with the notion that the two proteins may be differentially regulated through phosphorylation (Figure 8c ). It is possible that differential N-terminal phosphorylation influenced the recovery of peptide fragments for MS/MS sequencing and explains the migration (Figures 7 and 8) , kinetochore-binding (Figure 6 ), and checkpointfunction (Figures 3-5 ) differences between primate and rodent MAD1 proteins. Phospho-mass spectrometry experiments are in progress to identify all of the phosphorylated residues in human and mouse MAD1 and to understand how these sites may be regulated differently.
Discussion
That rodent cells are more tolerant of microtubule toxin than human cells has been well-established (Midgley et al., 1959; Ling and Thompson, 1974) . However, the underlying reason for this behavior, which is not explained by simple differences in intracellular drug concentrations (Rieder and Maiato, 2004) , is not yet understood. Recent characterizations of the eukaryote SAC (Musacchio and Hardwick, 2002; Shah and Cleveland, 2000) raise the possibility of explaining this divergent response based on physical/functional differences between rodent and human checkpoint components. A priori, one might expect that there could be multiple differences between rodents and primates which combine to contribute distinctive nocodazole responses. Here, we show that singular ectopic expression of human MAD1 in mouse and hamster cells sufficiently complemented a relaxed SAC to a more stringent format. Our findings suggest that within the context of our assay, MAD1 (and no additional spindle checkpoint component) is determinative of differential checkpoint stringency between rodents and human. Unexpectedly, while cDNA sequences revealed that human and rodent MAD1 proteins are well conserved and are different in size by only one amino acid (Figure 2) , we observed that the SDS-PAGE migrations of primate and rodent MAD1 proteins varied by an estimated B3 kDa (Figure 8a ). The latter finding could be explained if there existed different post-translational modifications such as differential phosphorylation. Indeed, the reproducibly different peptide recoverability of the extreme N-terminal fragment of murine and human MAD1 in MS/MS sequencing, while not providing proof, is consistent with this hypothesis (Figure 8b) . By 2-D isoelectric focusing gel analysis, the evidence supports that both human and mouse MAD1 proteins are phosphorylated at several sites with species-distinct patterns (Figure 8c ). We note with interest that our functional experiments also mapped species-specific affinity for kinetochore and stringency of response to nocodazole (Figures 6 and 7) to the N-terminus of MAD1. Our results are in agreement with previous suggestions by others that the N-terminal coiled-coiled domain of MAD1 contributes to kinetochore localization (Chen et al., 1998; Luo et al., 2002) . Additional experiments remain needed to fully delineate if (and on which N-terminal residues) MAD1, like MAD2 (Wassmann et al., 2003) , can be functionally regulated by phosphorylation.
To date, a defined function for MAD1 is its kinetochore recruitment of MAD2 (Sironi et al., 2001; Chung and Chen, 2002) . While MAD1 is dispensible in vitro for the formation of a MAD2-containing Figure 6 GFP-muMAD1 and GFP-hsMAD1 show differential ability to localize to heterologous kinetochores. Rodent (NIH3T3) and human (HeLa) cells were transiently transfected with either GFPhsMAD1 (top) or GFPmuMAD1 (bottom). At 24 h after transfection, live cells were stained with Hoechst 33324. The cells were visualized for GFPMAD1 (green) and DNA (blue) by confocal imaging. Cells depicted in this figure are in prometaphase and are representative of several fields. The left panels (a, e, c, g) of each pair show DIC images, while the right panels (b, f, d, h) show a three-dimensional image of a DNA/GFP-overlay of the same cells. GFPhsMAD1 showed a typical speckled kinetochore staining pattern in both rodent (b) and human cell (d), while GFPmuMAD1 showed kinetochore localization in rodent (f), but not human (h) cell.
MAD1 and stringent spindle checkpoint K Haller et al complex that can engage and arrest the APC/C (Fang, 2002) , in vivo, MAD1 directed localization of MAD2 to the kinetochore is required to activate the latter's APC/ C arrest function (Nasmyth, 2005 ). MAD1's 540-551 amino acids bind MAD2 (Luo et al., 2004; De Antoni et al., 2005) . Here, we note that the 540-551 regions of human, mouse, and hamster MAD1 are essentially identical in sequence (Figure 2) , arguing that inside mammalian cells differential binding by primate and rodent MAD1 for MAD2 unlikely explains SAC stringencies. Instead, our current results propose that differential affinity between the N-terminus of primate and rodent MAD1 for mammalian kinetochores (Figure 7) correlates well with previously reported SAC stringency differences between human, mouse, and hamster cells (Kung et al., 1990) . Whether affinity of Red sequences show tryptic peptides sequenced by MS/MS for either hsMAD1 (top) or muMAD1 (bottom). Results shown are representative of two independent assays. Note the failure to obtain sequencing information from the virtually identical extreme Nterminal peptide for muMAD1 (black italic, bottom), which differs from the hsMAD1 N-terminal fragment at two potential phosphoacceptor residues. (c) Two-dimensional isoelectric focusing analysis of human (HeLa cell, top) and mouse (NIH3T3 cell, bottom) MAD1 proteins. Tailed-arrows show corresponding spots between human and mouse MAD1. Tailless arrowheads point to spots seen for muMAD1, but not hsMAD1.
MAD1 for kinetochores is regulated by post-translational phosphorylation remains to be fully defined (Figure 8c; and Chi, unpublished observation) . We caution that most of our current interpretations are based on transfection studies which generally overexpress MAD1 proteins 5-10 times more than that seen ambiently in cells. To address this issue in a more physiologically stringent manner, we have created MAD1 heterozygous knockout (i.e. MAD1 þ /À) mice (Iwanaga et al., in preparation) . We are in the process of trying to generate through breeding MAD1 homozygous knockout mice, although these attempts have been complicated by emerging data that the MAD1 À/À genotype is embryonically lethal (Jeang, unpublished data) .
Our findings may be relevant to long-standing observations that mouse cells become transformed in vivo at a vastly higher rate than human cells. It is worth noting that the different rates of transformation between mouse and human occur despite the fact that the number of events required for tumor conversion and progression appears to be the same between rodents and primates (Holliday, 1996) . We speculate that a plausible reconciliation of these two observations may reside in the former being more tolerant of karyotypic destabilization than the latter. Accordingly, one scenario is that the relaxed mouse SAC phenotype facilitates genome destabilization and promotes the acquisition of a mutator phenotype, which accelerates the acquisition of additional changes that ultimately and stochastically provoke neoplastic transformation.
If the above reasoning is valid, is there any natural evidence which supports rodents being more tolerant than primates for chromosomal segregation mistakes and resulting chromosomal heterogeneity? Phylogenetic data offer some speculative findings. First, the rodentia order is vastly more diverse than the primate order. Thus, rodents include over 1700 different species while primates encompass only 93 species. Second, among species, there appears to be greater genome size variation between rodents than between primates. For instance, the 2n diploid genome numbers in African and South American hystricognath rodents range from 30 to 102 (Gallardo et al., 2003) . By comparison, the 2n chromosomal numbers between humans and the three species of living great apes (orangutan, gorilla and chimpanzee) vary only between 46 and 48 (Yunis and Prakash, 1982) . Conceivably, tolerance of chromosomal segregation errors presents an advantage for promoting greater speciation in rodents while at the same time it serves a disadvantage in conferring a higher associated risk for neoplasia. On balance, the greater longevity of humans (i.e. (wo)man lives on average 30-50 times longer than mouse) over rodents means that each neoplastic transformation incurs a greater cost to a (wo)man than to a mouse. This cost-benefit principle may compel long-lived species to become more vested in somatic genomic maintenance mechanisms than their shorter-lived counterparts. A more efficient primate MAD1 that guides a more stringent SAC may have evolved as a molecular solution to guard man's greater evolutionary investment.
Finally, the SAC differences described here for rodent and human cells offer added insight to cellular transformation by human viruses. In biological models for studying how T cells are transformed by human T-cell leukemia virus (HTLV-1) into adult T-cell leukemia (ATL; reviewed in Takatsuki, 2005) , it has been relatively easy to use the HTLV-1 Tax oncoprotein to convert rodent cells to neoplastic growth (Tanaka et al., 1990; Grossman et al., 1995; Yamaoka et al., 1996; Matsumoto et al., 1997) . On the other hand, attempts to comparably and fully transform primary human cells with Tax have remained stubbornly difficult (Grassmann et al., 1992; Rosin et al., 1998) . Based on our current data, one explanation, which does not exclude others, is that the higher stringency of primate MAD1, compared to rodent MAD1, checkpoint function confers a greater barrier to humans against transformation.
Materials and methods

Cells and plasmids
Adherent cells (HeLa, A549, Rat-2, CHO, NIH3T3, and MEF) were cultured in complete DMEM (Invitrogen), supplemented with 10% fetal bovine serum (FBS) (HyClone), glutamine, and penicillin/streptomycin (Gemini Bio Products). All MAD1 expression plasmid are based on cloning behind the CMV-immediate early promoter driven pCDNA3.0 vector (Invitrogen). For cloning, we used the hsMAD1 (accession number AF083811), muMAD1 (accession number AF083812), and hamster MAD1 (accession number AY247792) cDNAs as described in GenBank. Mouse (accession number U83902) and human (accession number U65410) MAD2 expression vectors were similarly cloned using pCDNA3.0. EGFP vectors and cloning of GFP-MAD1fusion protein plasmids were as previously described . Detailed information and sequences of plasmids are available upon request.
Western blotting
Western blotting was performed as previously described . Antisera used were rabbit serum raised against GST-hsMAD1 or GST-hsMAD2 and used at 1:1000 dilution, or mouse monoclonal anti-hsMAD1 (MBL International Corp.) used at 1:1000 dilution. Incubation with primary antibody was followed with goat anti-rabbit or goat antimouse alkaline phosphatase-conjugated secondary antibody. Detection of secondary antibody was by chemiluminescence (Tropix).
Immunofluorescence Cells were seeded into chambers with cover slip bottoms and grown overnight at 371C in a CO 2 incubator and than transfected with 500 ng of the indicated plasmids using lipofectamine-PLUS reagent according to the manufacturer's protocol (Invitrogen). Live cells were stained by adding directly Hoechst 33324 to a final concentration of 2 mg/ml into the culture media. Cells were visualized with a Leica DMIRE confocal microscope (Leica Microsystems GmbH, Mannheim, Germany). Imaris 3.0.6 software (Bitplane AG, Zurich, Switzerland) was used to merge images.
Mitotic index assay
Nocodazole (0.5 mM) was added to the media. At each time point, cells were washed with PBS and fixed with 1% formaldehyde-0.2% glutaraldehyde. DNA was stained with Hoechst 33258 dye (Sigma), 10 mg/ml, for 10 min at room temperature. A minimum of 300 cells were counted each time for three times to determine the percentage of viable cells arrested in mitosis.
Modified MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay Cell viability was measured by the Cell Counting Kit-8 (Dojindo) according to the manufacturer's protocol. Briefly, cells were incubated with WST-8 (tetrazolium salt), a modified form of MTT, which produces a dye upon bioreduction in viable cells. The colorimetric assay was performed in a Bio-Tek EL x 800 microplate reader.
Tandem mass spectrometry sequencing MAD1 protein bands from human HeLa and mouse NIH3T3 cells were identified by Western blotting and were aligned against molecular weight markers and excised from parallel Coomassie blue-stained gels. The gel slices were extensively washed and proteins were recovered and subjected to tryptic digestion. Tryptic peptides were sequenced by standard tandem MS/MS mass spectroscopy using the QSTAR XL mass spectrometer. Sequencing and analysis of amino acids were performed by the NIAID, research technology branch core facility.
